Reliq Health Technologies Inc.
RQHTF · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $5 | $4 | $3 | $2 |
| % Growth | 15.1% | 18.6% | 51.7% | – |
| Cost of Goods Sold | $2 | $3 | $3 | $2 |
| Gross Profit | $3 | $1 | $0 | $1 |
| % Margin | 67.5% | 34.4% | 13.4% | 23.4% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $2 | $1 |
| SG&A Expenses | $2 | $0 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $1 | $1 | $2 |
| Operating Income | $1 | -$0 | -$1 | -$1 |
| % Margin | 12.9% | -0.2% | -21% | -54.7% |
| Other Income/Exp. Net | $0 | -$0 | $1 | $0 |
| Pre-Tax Income | $1 | -$0 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | -$0 | -$0 | -$1 |
| % Margin | 15.4% | -1.7% | -3.5% | -43.5% |
| EPS | 0.004 | -0 | -0.001 | -0.005 |
| % Growth | 1,100% | 33.3% | 88.7% | – |
| EPS Diluted | 0.004 | -0 | -0.001 | -0.005 |
| Weighted Avg Shares Out | 183 | 196 | 189 | 189 |
| Weighted Avg Shares Out Dil | 183 | 196 | 189 | 189 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | -$0 | -$1 | -$1 |
| % Margin | 13.5% | -1.8% | -20.2% | -41.6% |